Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 99 | ECE2024

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

Card image cap
We are pleased to announce that ECE 2024 will be held in Stockholm, Sweden from 11-14 May 2024. We will, once again, be offering the hybrid format next year so you can join us in person in Sweden or remotely with ECE@Home.

Oral Communications

Oral Communications 8: Thyroid

ea0099oc8.1 | Oral Communications 8: Thyroid | ECE2024

Autonomous AI-based diagnostic system for predicting malignancy in thyroid nodules

Dominguez Cardenas Saturnino

Introduction: The present study investigates the efficacy of an autonomous diagnostic system that employs artificial intelligence (AI) for the prediction of malignancy in thyroid nodules. The study focuses on evaluating the performance of this AI-based system in detecting malignant thyroid nodules, with the aim of improving diagnostic accuracy and patient outcomes. AI, with its ability to analyze large amounts of complex data and identify patterns that may be difficult for hum...

ea0099oc8.2 | Oral Communications 8: Thyroid | ECE2024

Antigen-specific peptide immunotherapy attenuates the pathogenic response in a murine model of Graves’ disease

Cho Yi-Li , Wenhart Clara , Gobel Silvia , Reimann Andreas , Li Zhongmin , Munch Gotz

Background: Graves’ disease (GD) is an autoimmune disease caused by autoantibody targeting the thyrotropin receptor (TSHR) in the thyroid gland, resulting in hyperthyroidism with an annual incidence of 15 to 80/100,000 people worldwide. Current mainstream treatments for GD include aggressive treatment with radioiodine and thyroidectomy or unspecific immune-modulating therapy with glucocorticoids, antithyroid medications or anti-CD20 antibodies like Rituximab. Therefore, o...

ea0099oc8.3 | Oral Communications 8: Thyroid | ECE2024

Magnetic resonance imaging characteristics of Graves orbitopathy with elevated IgG4 serum concentration

Olejarz Michał , Martelus Marika , Szczepanek-Parulska Ewelina , Wrotkowska Elżbieta , Katulska Katarzyna , Ruchala Marek

Background: Graves disease with elevated Immunoglobulin G4 serum concentration is a novel subtype of Graves disease (GD), which seems to be particularly associated with Graves orbitopathy (GO). It occurs in 17.6% of patients with GO and 5.4% of patients with GD without GO. In this study, we compare multiple magnetic resonance imaging (MRI) features of GO with elevated IgG4 serum concentration (IgG4-GO) with the classic GO subtype without IgG4 elevation. No such research has be...

ea0099oc8.4 | Oral Communications 8: Thyroid | ECE2024

The significance of 3-nitrotyrosine quantification in angioinvasive papillary thyroid carcinoma

Buczyńska Angelika , Kościuszko Maria , Wiatr Aleksandra , Adamska Agnieszka , Siewko Katarzyna , Dzieciol Janusz , Popławska-Kita Anna , Krętowski Adam

Angioinvasion in papillary thyroid cancer (PTC) is a crucial determinant of patient prognosis. 3-Nitrotyrosine (3-NT) is a byproduct resulting from the interaction between nitric oxide and tyrosine, serving as a discernible marker indicative of oxidative stress. Within the context of PTC, oxidative stress plays a pivotal role in carcinogenic processes, particularly concerning angioinvasion. Patients with elevated levels of oxidative stress are correlated with an unfavorable cl...

ea0099oc8.5 | Oral Communications 8: Thyroid | ECE2024

"Epithelial and stromal landscape heterogeneity at spatial resolution in autoimmune thyroid diseases"

Sacristan- Gomez Pablo , Sanchez de la Blanca Nuria , Serrano Somavilla Ana , Munoz de Nova Jose Luis , Sampedro Nunez Miguel , Marazuela Monica , Martinez Hernandez Rebeca

Introduction: Autoimmune thyroid diseases (AITD) such as Graves’ disease (GD) or Hashimoto’s thyroiditis (HT) are autoimmune, organ-specific diseases probably related to a complex and multifactorial interplay of specific susceptibility genes and environmental exposures. T lymphocytes and their secretory cytokines play indispensable roles in disrupting tolerance. However, their roles are often complex and full of interactions among distinct components of the thyroid e...

ea0099oc8.6 | Oral Communications 8: Thyroid | ECE2024

Filamin A is required for RET expression and signaling in medullary thyroid carcinoma (MTC) cells

Marra Giusy , Catalano Rosa , Nozza Emma , Lopez Gianluca , Contarino Andrea , Dolci Alessia , Iofrida Elisabetta , Mantovani Giovanna , Peverelli Erika

Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor originating from parafollicular thyroid C cells that produce calcitonin, accounting for 5%-10% of thyroid cancers. In all inherited cases of MTC, and in about 40% of sporadic cases, activating mutations of the receptor tyrosine kinase proto-oncogene RET are found. Signaling pathways involved in cell proliferation, survival and motility are triggered by constitutively active RET, but the mechanisms underlying mali...